
The CHI-sponsored fourth annual meeting, held at the Sheraton hotel in Boston, USA, was attended by approximately 120 delegates, mainly from the pharmaceutical and biotechnology industries. The theme of the conference focused on new developments and validation of current techniques in structure-based drug design, as well as the successful application of these methods in drug development.

